About Genewiz
Genewiz is a company based in South Plainfield (United States) founded in 1999 by Amy Liao and Steve Sun was acquired by Brooks Automation in September 2018. The company has 452 employees as of December 31, 2022. Genewiz has completed 1 acquisition, including Beckman Coulter Genomics. Genewiz offers products and services including Next Generation Sequencing, Sanger Sequencing, Gene Synthesis, Plasmid Preparation, and Oligo Synthesis. Genewiz operates in a competitive market with competitors including Novogene Corporation, Rejuvenate Bio, Source BioScience, Beikang Medical and Macrogen, among others.
- Headquarter South Plainfield, United States
- Employees 452 as on 31 Dec, 2022
- Founders Amy Liao, Steve Sun
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$143.28 K (USD), Grant
Jun 01, 2020
-
Investors
Brooks Automation
& 4 more
-
Employee Count
452
as on Dec 31, 2022
- Investments & Acquisitions
-
Acquired by
Brooks Automation
(Sep 26, 2018)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Genewiz
Genewiz offers a comprehensive portfolio of products and services, including Next Generation Sequencing, Sanger Sequencing, Gene Synthesis, Plasmid Preparation, and Oligo Synthesis.
High-throughput DNA sequencing for research applications
Accurate DNA sequencing for mutation analysis
Custom DNA and RNA synthesis for experiments
Standard and targeted plasmid DNA prep services
Custom DNA and RNA oligos for sequencing
People of Genewiz
Unlock access to complete
Unlock access to complete
Software Development Team
50 people
Sales and Marketing
39 people
Leadership Team
24 people
Senior Team
19 people
Account Team
17 people
Finance and Accounting
16 people
Legal and Compliance
9 people
Human Resources and Administration
9 people
Unlock access to complete
Funding Insights of Genewiz
Investors in Genewiz
Genewiz has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include Brooks Automation, Orbimed and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields.
|
Locked | Locked | Locked | |
|
Ampersand Capital Partners is focused on investments in healthcare and life sciences.
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for Genewiz
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Genewiz
Genewiz has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Beckman Coulter Genomics.
Investment portfolio details for Genewiz
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Next-generation and Sanger sequencing services are provided.
|
Locked | Locked | 2008 | Locked |
Complete acquisition details for Genewiz
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Genewiz
Detailed financials for Genewiz
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Genewiz Comparisons
Peer comparison for Genewiz
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Genewiz
Genewiz operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Novogene Corporation, Rejuvenate Bio, Source BioScience, Beikang Medical and Macrogen, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Genomic services and solutions with NGS expertise are provided.
|
|
| Locked | Locked | Locked |
Gene-editing platform and anti-aging therapy for dogs are developed.
|
|
| Locked | Locked | Locked |
Multiple genomic services are provided for analysis and diagnostics.
|
|
| Locked | Locked | Locked |
NGS-based diagnostic solutions for neonatal screening are developed.
|
|
| Locked | Locked | Locked |
Next-generation sequencing and genomics services are provided globally.
|
|
| Locked | Locked | Locked |
Genome sequencing, analysis, and genetic screening services are provided.
|
Detailed competitors of Genewiz
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Genewiz
Complete news archive for Genewiz
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Genewiz
Genewiz was founded in 1999 and raised its 1st funding round 17 years after it was founded.
Genewiz is headquartered in South Plainfield, United States. It is registered at South Plainfield, New Jersey, United States.
Amy Liao is the current CEO of Genewiz. They have also founded this company.
As of Dec 31, 2022, the latest employee count at Genewiz is 452.
Genewiz was founded in 1999 and is headquartered in South Plainfield, United States. Operations focus on the life sciences sector, where a variety of genomic services are delivered, including DNA sequencing, gene synthesis, plasmid preparation, site-directed mutagenesis, fragment analysis, SNP discovery sequencing, next-generation sequencing, bioinformatics, and GLPcGMP regulatory support. Molecular biology services are also offered to support research and development needs.
Genewiz's top competitors include Novogene Corporation, Source BioScience and Macrogen.
Genewiz offers Next Generation Sequencing, Sanger Sequencing, Gene Synthesis, Plasmid Preparation, and Oligo Synthesis.
Genewiz has made 1 acquisition, including Beckman Coulter Genomics.
Genewiz has 5 investors. Key investors include Brooks Automation, Orbimed, European Union, Ampersand Capital Partners, and PrimeValue Capital Management.